top of page
keifeladyhero.jpg

About Us

Scroll to learn more

Meet The Team

Our leadership team has diverse professional experience across the biopharma ecosystem including an established track record in brain function discovery and multiple neurological drug regulatory approvals. This team is building on the successful preclinical and clinical research conducted at Georgetown University by members of our scientific team.  

We are on a mission to improve the outcomes for patients with neurodegenerative diseases and their families.

Chris Hoyt

CEO

Charbel Moussa, MBBS, PhD

Co-Founder & Director SAB

Alison Finger

Director

Garrett Vygantas, MD

Director

Dan Feehan

Director

PastedGraphic-1.jpg

Peter Adler

Director

bottom of page